← Leaderboards
Christopher Blair Cooper
Global Alliance For Tb Drug Development
$1,061,077
Attributed
$1,061,077
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $850.9K · FY2021–23$1M$750K$500K$250K$0
'21
'22
'23
Funding mix
By agency
NIH$1,061,077 · 1
By mechanism
U19$1,061,077 · 1
Top collaborators
No co-investigators on record.
Most similar at Global Alliance For Tb Drug Development
Same institution · by research overlap
- Nader Fotouhi$4,211,449
- Anna Upton$10,496,979
- Khisimuzi E. Mdluli$328,954
Others in their field
Other Emerging Leaders on “Improved Outcome”
- Chanza Baytop · Westat, Inc.$271,217,917
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$145,933,707
- Peter W Pisters · University Of Tx Md Anderson Can Ctr$56,084,949
- Susan Abushakra · Alzheon, Inc.$47,265,244
- Scott Hensley · University Of Pennsylvania$44,383,572
- Abraham Aizer Brody · New York University School Of Medicine$39,891,529
Research focus
Improved OutcomeAnti-Bacterial AgentsGrowthBacterial RnaBactericideBindingAbsorptionFollow-UpCollaborationsDesignDna-Directed Rna PolymeraseDrug CandidateDrug DevelopmentDrug KineticsBinding SitesAnimal ModelClinicExtreme Drug Resistant TuberculosisDrug-SensitiveEfficacy StudyEthambutolEvaluationEventInferior